TNI BioTech, Inc. (PINKSHEETS: TNIB) announced that it acquired exclusive licensing rights to all of the proprietary technical information, know-how, procedures, IND, protocols, methods, prototypes, designs, data and reports, which are not readily available to others through public means, and which are owned, generated or developed through experiments or testing by Dr. Bernard Bihari.
TNI BioTech, Inc. acquired the portfolio for 500,000 shares of the company's stock and other consideration. As part of the agreement, the company agreed to maintain the patents and, in cases where additional patents have not been maintained in the last two years, TNI BioTech, Inc. plans to petition the United States Patent and Trademark Office to revive them immediately.
Disclosure: Please be advised that OTCtipReporter.com has been compensated seven thousand five hundred dollars cash by a non-affiliated third party to profile TNIB for a one day investor awareness program. We Own NO Shares.
We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by OTC Tip Reporter. Please be advised that the information provided May or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed. To view a complete disclaimer, visit: http://www.otctipreporter.com/disclaimer.htm